Academic Journal
Patients' and clinicians' knowledge in cancer-related cognitive impairment and its implications: current perspective.
| Τίτλος: | Patients' and clinicians' knowledge in cancer-related cognitive impairment and its implications: current perspective. |
|---|---|
| Συγγραφείς: | Ferrari MV; Applied Research Division for Cognitive & Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, 20141, Italy., Conti L; Applied Research Division for Cognitive & Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, 20141, Italy., Capetti B; Applied Research Division for Cognitive & Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, 20141, Italy., Marzorati C; Applied Research Division for Cognitive & Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, 20141, Italy.; Department of Oncology & Haemato-Oncology, University of Milan, Milan, 20122, Italy., Grasso R; Applied Research Division for Cognitive & Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, 20141, Italy.; Department of Oncology & Haemato-Oncology, University of Milan, Milan, 20122, Italy., Pravettoni G; Applied Research Division for Cognitive & Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, 20141, Italy.; Department of Oncology & Haemato-Oncology, University of Milan, Milan, 20122, Italy. |
| Πηγή: | Future oncology (London, England) [Future Oncol] 2024 Dec; Vol. 20 (40), pp. 3569-3578. Date of Electronic Publication: 2024 Nov 12. |
| Τύπος έκδοσης: | Journal Article; Review |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2024- : [Milton Park, Oxfordshire] : Taylor & Francis Original Publication: London : Future Medicine Ltd., c2005- |
| Ιατρικοί όροι (MeSH): | Neoplasms*/complications , Neoplasms*/psychology , Neoplasms*/therapy , Cognitive Dysfunction*/etiology , Cognitive Dysfunction*/diagnosis , Cognitive Dysfunction*/psychology , Health Personnel*/psychology , Health Knowledge, Attitudes, Practice*, Humans ; Health Literacy ; Quality of Life |
| Περίληψη: | Health literacy is essential in cancer care. Low health literacy compromises the capacity to maintain one's health through self-management and collaboration with healthcare providers, especially when facing cognitive side effects related to cancer and its treatments. Cancer-related cognitive impairment (CRCI) is a common phenomenon among cancer patients and might determine a significant impact on their quality of life, yet it is still under identified by both clinicians and patients. This perspective aims to discuss the implications of patients' and healthcare professionals' lack of awareness on the matter and argues about the importance of improving the level of information on CRCI to mitigate difficulties in identifying and managing such manifestations on various levels. |
| References: | Nat Rev Clin Oncol. 2011 May 31;8(7):444. (PMID: 21629214) J Pers Soc Psychol. 1999 Jan;76(1):114-28. (PMID: 9972557) Lancet Oncol. 2014 Mar;15(3):258-60. (PMID: 24503530) Appl Neuropsychol Adult. 2025 Nov-Dec;32(6):1803-1818. (PMID: 38261545) Cancer. 2019 Jun 15;125(12):1958-1962. (PMID: 30668896) J Environ Health Sci. 2020;6(1):. (PMID: 33604453) Neurosci Biobehav Rev. 2013 Sep;37(8):1311-21. (PMID: 23660455) Psychooncology. 2009 Jun;18(6):674-8. (PMID: 19021129) Am Psychol. 1997 Jun;52(6):613-29. (PMID: 9174398) J Oncol Pharm Pract. 2016 Jun;22(3):437-47. (PMID: 26044586) Soc Sci Med. 2019 Apr;226:47-55. (PMID: 30844672) Health Psychol Open. 2018 Dec 05;5(2):2055102918815318. (PMID: 30619617) Patient Educ Couns. 2022 Aug;105(8):2763-2770. (PMID: 35465976) Front Mol Biosci. 2021 Dec 14;8:770413. (PMID: 34970595) JNCI Cancer Spectr. 2019 Nov 29;4(1):pkz099. (PMID: 32064458) Neurol Sci. 2019 Sep;40(9):1759-1774. (PMID: 31049790) Clin J Oncol Nurs. 2005 Dec;9(6):713-21. (PMID: 16381547) Cancers (Basel). 2019 Nov 28;11(12):. (PMID: 31795208) Ann Oncol. 2016 Oct;27(10):1909-15. (PMID: 27551051) Health Psychol Open. 2019 Mar 05;6(1):2055102919832234. (PMID: 30873289) Ann Oncol. 2019 Dec 1;30(12):1925-1940. (PMID: 31617564) Patient Educ Couns. 2009 Mar;74(3):295-301. (PMID: 19150199) Crit Rev Oncol Hematol. 2022 Dec;180:103859. (PMID: 36257539) Lancet Oncol. 2011 Dec;12(13):1181-2. (PMID: 21944597) Health Expect. 2021 Apr;24(2):617-627. (PMID: 33539611) Soc Indic Res. 2010 Apr;95(2):325-338. (PMID: 41541816) Fam Med Community Health. 2020 May;8(2):. (PMID: 32414834) Support Care Cancer. 2020 Apr;28(4):1649-1658. (PMID: 31286234) Br J Health Psychol. 2023 Feb;28(1):252-270. (PMID: 36086995) J Health Soc Behav. 2020 Sep;61(3):259-273. (PMID: 32723112) Oncol Nurs Forum. 2016 Sep 1;43(5):602-16. (PMID: 27541553) CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338) J Eval Clin Pract. 2011 Aug;17(4):594-6. (PMID: 21679280) J Phys Act Health. 2020 Oct 31;17(12):1259-1274. (PMID: 33129198) Am Soc Clin Oncol Educ Book. 2018 May 23;38:795-806. (PMID: 30231372) Psychooncology. 2012 Oct;21(10):1132-5. (PMID: 21769988) Front Psychiatry. 2020 Sep 29;11:577871. (PMID: 33132937) BMC Health Serv Res. 2022 Sep 12;22(1):1148. (PMID: 36096793) BMC Cancer. 2022 Sep 23;22(1):1008. (PMID: 36138381) J Formos Med Assoc. 2014 Jan;113(1):33-41. (PMID: 23611453) Brain Behav Immun. 2013 Mar;30 Suppl:S117-25. (PMID: 22613170) J Cancer Surviv. 2018 Apr;12(2):178-185. (PMID: 29080061) Psychol Health. 2017 Jan;32(1):78-93. (PMID: 27701901) J Clin Oncol. 2017 Feb 10;35(5):506-514. (PMID: 28029304) PLoS One. 2020 Jun 19;15(6):e0234926. (PMID: 32559237) Neurosci Biobehav Rev. 2018 Sep;92:304-317. (PMID: 29791867) Hum Brain Mapp. 2014 Mar;35(3):889-99. (PMID: 23281152) Cancer. 2020 Dec 15;126(24):5328-5336. (PMID: 32996583) J Health Commun. 2015;20 Suppl 2:69-76. (PMID: 26513033) Sci Rep. 2022 Feb 8;12(1):2135. (PMID: 35136066) Health Educ Monogr. 1978;6(Suppl. 1):18-27. (PMID: 11650649) Crit Rev Oncol Hematol. 2022 Aug;176:103728. (PMID: 35662585) Psychooncology. 2007 Sep;16(9):834-42. (PMID: 17120276) Cancer. 1996 Mar 1;77(5):983-95. (PMID: 8608494) Int J Environ Res Public Health. 2020 Dec 24;18(1):. (PMID: 33374440) J Cancer Policy. 2023 Mar;35:100375. (PMID: 36462750) J Cancer Surviv. 2024 Dec;18(6):1974-1997. (PMID: 37934312) Psychooncology. 2023 Feb;32(2):214-228. (PMID: 36443527) CA Cancer J Clin. 2015 Mar;65(2):123-38. (PMID: 25483452) Cancers (Basel). 2023 Nov 08;15(22):. (PMID: 38001592) Neuropsychol Rev. 2020 Sep;30(3):287-309. (PMID: 32607817) Neural Plast. 2024 Apr 13;2024:6344925. (PMID: 38645612) Lancet Oncol. 2011 Jul;12(7):703-8. (PMID: 21354373) Support Care Cancer. 2021 Jun;29(6):2821-2840. (PMID: 33231809) Gen Hosp Psychiatry. 2023 Sep-Oct;84:271-272. (PMID: 37407422) BMC Public Health. 2012 Jan 25;12:80. (PMID: 22276600) Support Care Cancer. 2022 Jun;30(6):4729-4738. (PMID: 35122530) Front Immunol. 2018 Jun 07;9:1195. (PMID: 29930550) Transl Oncol. 2022 Feb;16:101297. (PMID: 34896851) Expert Rev Neurother. 2023 Mar;23(3):249-268. (PMID: 36951414) |
| Grant Information: | 5 × 1000 Funds; Italian Ministry of Health with Ricerca Corrente |
| Contributed Indexing: | Keywords: cancer; cancer-related cognitive impairment; cognition; health literacy; patient education; physician-patient communication; treatment side-effects Local Abstract: [plain-language-summary] [Box: see text]. |
| Entry Date(s): | Date Created: 20241112 Date Completed: 20250124 Latest Revision: 20260923 |
| Update Code: | 20260923 |
| PubMed Central ID: | PMC11776859 |
| DOI: | 10.1080/14796694.2024.2421148 |
| PMID: | 39530545 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!